Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study

被引：2
作者：
Chapman, Kenneth R.
Vogelmeier, Claus F.
FowlerTaylor, Angel
Ayers, Tim
Thach, Chau
Shrinivasan, Anupama
Fogel, Robert
Patalano, Francesco
Banerji, Donald
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Bronchodilators; COPD; -; exacerbations; Treatments;
D O I：
10.1183/13993003.congress-2016.PA296
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA296
引用
收藏
页数：2
相关论文
共 21 条
[21]   Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study [J].
Kerstjens, Huib A. M. ;
Maspero, Jorge F. ;
Chapman, Kenneth R. ;
Van Zyl-Smit, Richard ;
Tanase, Ana-Maria ;
Lawrence, David ;
Pethe, Abhijit ;
Mezzi, Karen ;
D'Andrea, Peter .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
123